echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Safety of Nicardipine

    The Safety of Nicardipine

    • Last Update: 2023-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Nicardipine is a calcium channel blocker medication that is primarily used to treat hypertension (high blood pressure) and angina (chest pain).
    It is also sometimes used to treat other conditions, such as Raynaud's disease and migraine headaches.
    Nicardipine is available in a number of countries around the world, including the United States, Canada, and Europe, but it is not currently approved for use in all countries.


    In terms of safety, nicardipine is generally considered to be a safe medication when used as directed.
    However, as with all medications, there are some potential risks and side effects associated with its use.
    These side effects are usually mild and may include headache, dizziness, and flushing.
    More serious side effects are rare, but they can occur in some people.


    One potential risk associated with nicardipine use is the risk of hypotension (low blood pressure).
    This can occur if the medication is taken with other medications that lower blood pressure, or if the patient is dehydrated or otherwise compromised.
    Low blood pressure can cause symptoms such as dizziness, lightheadedness, and fainting, and can be dangerous if it becomes severe.


    Another potential risk associated with nicardipine use is the risk of heart failure.
    While the medication is generally effective at reducing blood pressure, it can also cause the heart to pump less efficiently, which can lead to heart failure in some people.
    This risk is generally higher in patients who have pre-existing heart conditions or who are taking other medications that can affect the heart.


    Pregnant women should not take nicardipine, as it can cause harm to the developing fetus.
    The safety of nicardipine in breastfeeding women is not well established, and the medication should be used with caution in this context.


    In addition to its potential risks and side effects, nicardipine can interact with other medications in potentially dangerous ways.
    Patients should always talk to their doctor about all medications they are taking, including over-the-counter medications, supplements, and prescription drugs, before starting nicardipine.
    This is especially important for patients who are taking other medications that lower blood pressure, as these medications can increase the risk of hypotension when taken with nicardipine.


    Overall, nicardipine is generally considered to be a safe medication when used as directed.
    However, its potential risks and side effects, as well as its interactions with other medications, should be carefully considered before starting treatment.
    Patients should always follow their doctor's instructions and report any side effects or other issues to their doctor as soon as possible.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.